• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Evaluation of the Pan Influenza Detection Kit Utilizing the PLEX-ID and Influenza Samples from the 2011 Respiratory Season

tetano

Editor, Senior Moderator
J Virol Methods. 2013 Jun 10. pii: S0166-0934(13)00219-X. doi: 10.1016/j.jviromet.2013.06.006. [Epub ahead of print]
Evaluation of the Pan Influenza Detection Kit Utilizing the PLEX-ID and Influenza Samples from the 2011 Respiratory Season.
Murillo L, Hardick J, Jeng K, Gaydos CA.
Source

The Johns Hopkins University School of Medicine, Division of Infectious Diseases, 855 North Wolfe Street, Rangos Building, Room 530, Baltimore, MD, 21205 United States. Electronic address: lmurill2@jhmi.edu.
Abstract

A comparison study was performed between the PLEX-ID and the CDC RT-PCR method for the detection and identification of Influenza A viruses using nasopharyngeal samples (N=75) collected between January and May 2011. Overall agreement was 89.3% (67/75 kappa=0.57 95% CI 0.3-0.89). Positive percent agreement was 92.3% (60/65); negative percent agreement was 70% (7/10). H1N1 pdm09 identified: 42.6% (32/75) and 54.7% (41/75) by PLEX-ID and CDC RT-PCR, respectively. H3N2 identified: 29.3% (22/75) and 32% (24/75) of samples by PLEX-ID and CDC RT-PCR, respectively. Negatives identified: 16% (12/75) and 13.3% (10/75), by PLEX-ID and CDC RT-PCR respectively. For Influenza viruses identified as H1N1 pdm 09, Influenza A virus A/NEW YORK/15/2009 (H1N1 pdm09) was the most prevalent genotype at 50% (16/32), followed by A/CALIFORNIA/05/2009(H1N1 pdm09) at 18.2% (6/32). Updated assay plates containing additional primers designed for H1N1 pdm 09 HA and NA genes were utilized for this evaluation. Among H1N1 pdm 09 samples, the HA gene was conserved in 96.9% (31/32) of samples. The NA gene was conserved in 96.9% (31/32).

Copyright ? 2013. Published by Elsevier B.V.

PMID:
23764420
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/23764420
 
Back
Top Bottom